This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Regulators authorize antibody treatment for omicron
U S health regulators approved Eli Lilly antibody therapy bebtelovimab for adults and teens with mild to moderate COVID-19, effective against omicron and BA2. The FDA clears the drug after prior antibodies failed against omicron and the government begins distributing about 600,000 doses. Lilly’s deal is valued at at least 720 million dollars.
MENTIONED IN THIS ARTICLE
Washington
U.S
Food and Drug Administration
Lilly
Biden Administration
Patrizia Cavazzoni
FDA
Drug Center
Omicron
Lilly Drug
Regeneron
Lilly’s